Death receptor 5 and neuroproliferation.

作者: Yanli Niu , Yongqiang Li , Jianfeng Zang , Hongen Huang , Jiexin Deng

DOI: 10.1007/S10571-011-9757-3

关键词: NeuroscienceNeurogenesisRostral migratory streamDentate gyrusSubventricular zoneStem cellCerebellumOlfactory bulbBiologyNeuroepithelial cellCell biology

摘要: Tumor necrosis factor-related apoptosis-inducing ligand or Apo2 is a member of the tumor factor superfamily cytokines that induces apoptosis upon binding to its death domain-containing transmembrane receptors, receptors 4 and 5 (DR4, DR5). However, DR5 also expressed in developing CNS where it appears play role unrelated apoptosis, instead may be involved regulation neurogenesis. We report on distribution expression mouse hippocampus, cerebellum, rostral migratory stream (RMS) olfactory bulb from embryonic (E) day 16 (E16) postnatal (P) (P180). At E16, DR5-positive cells were distributed widely hippocampus with strong immunostaining dentate gyrus. In newborn predominantly located proliferative zones, such as gyrus, subventricular zone, RMS. After 7 (P7), number decreased, intense fluorescence primarily restricted subgranular layer (SGL), although granular cell showed weak fluorescence. P30, only few found SGL, mature granule negative for expression. To address whether progenitor neurons, we performed 5-bromo-deoxyuridine labeling. SGL selectively express DR5, lower levels positive doublecortin, marker neurons. addition, stem intestine, RMS demonstrated DR5-positive. meantime, glial fibrillary acidic protein, Bergmann cells. conclude by neuroprogenitor suggesting receptor likely key neuroproliferation differentiation.

参考文章(50)
Christina Falschlehner, Tom M. Ganten, Ronald Koschny, Uta Schaefer, Henning Walczak, TRAIL and Other TRAIL Receptor Agonists as Novel Cancer Therapeutics Advances in Experimental Medicine and Biology. ,vol. 647, pp. 195- 206 ,(2009) , 10.1007/978-0-387-89520-8_14
Itaru Imayoshi, Masayuki Sakamoto, Toshiyuki Ohtsuka, Ryoichiro Kageyama, Continuous neurogenesis in the adult brain Development Growth & Differentiation. ,vol. 51, pp. 379- 386 ,(2009) , 10.1111/J.1440-169X.2009.01094.X
Ahmad R. Safa, Khadijeh Bijangi-Vishehsaraei, Soo Jung Park, Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cells. International journal of biochemistry and molecular biology. ,vol. 1, pp. 90- 100 ,(2010)
Lucas A. Mongiat, Alejandro F. Schinder, Adult neurogenesis and the plasticity of the dentate gyrus network. European Journal of Neuroscience. ,vol. 33, pp. 1055- 1061 ,(2011) , 10.1111/J.1460-9568.2011.07603.X
H Mori, S Sugie, N Yoshimi, A Hara, T Tanaka, Control of cell proliferation in cancer prevention Mutation Research. ,vol. 428, pp. 291- 298 ,(1999) , 10.1016/S1383-5742(99)00055-1
CNAM Oldenhuis, JH Stegehuis, AME Walenkamp, S de Jong, EGE de Vries, Targeting TRAIL death receptors Current Opinion in Pharmacology. ,vol. 8, pp. 433- 439 ,(2008) , 10.1016/J.COPH.2008.06.011
Preet M Chaudhary, Michael Eby, Alan Jasmin, Angela Bookwalter, Jessica Murray, Leroy Hood, Death Receptor 5, a New Member of the TNFR Family, and DR4 Induce FADD-Dependent Apoptosis and Activate the NF-κB Pathway Immunity. ,vol. 7, pp. 821- 830 ,(1997) , 10.1016/S1074-7613(00)80400-8
Su-Chang Lin, Yu-Chih Lo, Hao Wu, Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling Nature. ,vol. 465, pp. 885- 890 ,(2010) , 10.1038/NATURE09121
Elizabeth S. Henson, James B. Johnston, Spencer B. Gibson, The role of TRAIL death receptors in the treatment of hematological malignancies. Leukemia & Lymphoma. ,vol. 49, pp. 27- 35 ,(2008) , 10.1080/10428190701713655
Gen Sheng Wu, TRAIL as a target in anti-cancer therapy. Cancer Letters. ,vol. 285, pp. 1- 5 ,(2009) , 10.1016/J.CANLET.2009.02.029